Aehr Test Systems (NASDAQ:AEHR) Director Laura Oliphant Sells 1,717 Shares of Stock

Aehr Test Systems (NASDAQ:AEHR) Director Laura Oliphant sold 1,717 shares of Aehr Test Systems stock in a transaction on Wednesday, August 12th. The shares were sold at an average price of $133.00, for a total value of $228,361.00. Following the completion of the sale, the director directly owned 16,100 shares of the company’s stock, valued at $2,141,300. The trade was a 9.64% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this hyperlink.

Aehr Test Systems Trading Down 4.6%

AEHR opened at $123.30 on Friday. The stock’s 50-day moving average price is $92.12 and its 200 day moving average price is $71.00. Aehr Test Systems has a 12-month low of $16.38 and a 12-month high of $133.35. The firm has a market cap of $4.02 billion, a price-to-earnings ratio of -513.73 and a beta of 3.10.

Institutional Trading of Aehr Test Systems

Large investors have recently made changes to their positions in the company. Caitong International Asset Management Co. Ltd acquired a new stake in Aehr Test Systems in the fourth quarter valued at approximately $25,000. Advocate Investing Services LLC acquired a new position in Aehr Test Systems during the 2nd quarter worth approximately $26,000. Sunbelt Securities Inc. purchased a new stake in shares of Aehr Test Systems in the 3rd quarter valued at approximately $27,000. State of Wyoming purchased a new stake in shares of Aehr Test Systems in the 2nd quarter valued at approximately $28,000. Finally, KBC Group NV acquired a new stake in shares of Aehr Test Systems in the 1st quarter valued at $30,000. 69.69% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

AEHR has been the subject of a number of research reports. Weiss Ratings cut shares of Aehr Test Systems from a “sell (d)” rating to a “sell (e+)” rating in a report on Wednesday, July 29th. Lake Street Capital reissued a “buy” rating and issued a $110.00 price target on shares of Aehr Test Systems in a research report on Wednesday, July 15th. Zacks Research upgraded shares of Aehr Test Systems from a “hold” rating to a “strong-buy” rating in a research note on Friday, July 17th. Jefferies Financial Group started coverage on Aehr Test Systems in a research report on Thursday. They set a “buy” rating and a $175.00 price objective on the stock. Finally, Wall Street Zen upgraded Aehr Test Systems from a “sell” rating to a “hold” rating in a research note on Saturday, July 18th. Two equities research analysts have rated the stock with a Strong Buy rating, four have given a Buy rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of “Buy” and an average price target of $136.67.

Key Stories Impacting Aehr Test Systems

Here are the key news stories impacting Aehr Test Systems this week:

• Positive Sentiment: Aehr received a $22 million follow-on order from its lead customer for wafer-level burn-in systems used with advanced AI training and inference processors. The repeat order supports demand for Aehr’s FOX systems and strengthens the company’s position in AI and high-performance computing. Aehr Receives $22 Million Follow-on Order
• Positive Sentiment: Recent updates highlighted record quarterly bookings of $60.7 million, an approximately $100.6 million backlog and fiscal 2027 revenue guidance of $130 million to $150 million. These figures provide stronger revenue visibility and reinforce the growth opportunity from AI-chip testing. Aehr’s AI Order and WLBI Opportunity
• Neutral Sentiment: CEO Gayn Erickson and CFO Chris Siu are scheduled to meet investors at the Needham Virtual Semiconductor and SemiCap 1×1 Conference on August 19. The event could offer additional insight into demand, backlog conversion and fiscal 2027 execution, although no new financial information was announced. Aehr to Participate in Needham Conference
• Negative Sentiment: Insiders sold a combined 65,130 shares worth approximately $8.5 million on August 12. The sales included 40,000 shares from the CEO, 15,000 from the COO and additional shares from two directors. While the executives retained sizable positions, the transactions may encourage profit-taking and add selling pressure after the stock’s rapid advance. Aehr CEO Stock Sale Filing
• Negative Sentiment: Analyst commentary warns that AEHR now carries demanding expectations following its major gains. Its elevated valuation and negative earnings multiple leave the stock vulnerable to further declines if AI-related orders slow, backlog conversion disappoints or execution falls short.

About Aehr Test Systems

Aehr Test Systems develops, manufactures and sells semiconductor test and burn-in equipment used by device manufacturers to ensure quality and reliability of integrated circuits. Its products are designed for wafer-level reliability assessment, functional test and stress screening of memory devices, system-on-chips, optical components and power semiconductors. By focusing on wafer-level burn-in and testing processes, the company helps reduce cost and improve yield for high-volume semiconductor production.

The company’s product portfolio includes FOX series wafer probe test and burn-in systems as well as ABTS burn-in ovens.